Brief: GeNeuro Completes Patient Enrollment In Phase 2A Study Of GNbAC1 In Type 1 Diabetes

Geneuro SA

09/01/2018 17:01

Jan 9 (Reuters) - GENEURO SA  GNRO.PA : 
    * GENEURO COMPLETES PATIENT ENROLLMENT IN PHASE 2A STUDY OF 
GNBAC1 
IN TYPE 1 DIABETES 
    * AUSTRALIAN PHASE 2A CLINICAL TRIAL ENROLLED 60 ADULT 
PATIENTS IN 
MORE THAN 10 CENTERS 
    * DATA EXPECTED 3Q2018 
 
Source text for Eikon:  ID:nBwMQl6Sa  
Further company coverage:  GNRO.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))